Supporting Healing ♦ Teaching ♦ Research
Hadassah ResearchPrint

 
RESEARCH
 
Hadassah's physicians and scientists are actively engaged in a wide variety of extensive basic and clinical research projects, looking for new ways to treat current conditions. 
Over half the hospital research conducted in Israelis carried out at Hadassah. Each department incorporates research units and there are many interdisciplinary research centers. In both hospitals and within a number of hospital departments, Hadassah has created Centers of Excellence: brain trusts of scientists and physicians, integrating clinical care with the latest laboratory lessons.
Hadasit, Hadassah's Technology Transfer Company, promotes and commercializes the intellectual property and R&D capabilities continuously generated by Hadassah physicians and scientists. Hadasit's successful enterprising of Hadassah's biomedical technology - including novel therapeutics, diagnostics and devices - has gained Hadassah global recognition.
 
 
 
Hadassah Research in the News
 

Hadassah to Participate in Global Stem Cell Research Consortium on Alzheimer's Disease

The Hadassah Medical Center is one of the prestigious participants in a global consortium sponsored by the Cure Alzheimer's Fund (CAF), aimed at employing stem cells to eventually uncover the cure for Alzheimer's disease. Prof. Tamir Ben-Hur, M.D., Ph.D, head of Hadassah's Department of Neurology, is spearheading the research at Hadassah, which has received an initial grant of $100,000 from Cure for this purpose. Full Story

 

A multidisciplinary team of researchers at the Hadassah Medical Center have discovered the reason behind recurrent life-threatening infections in infants that has led to bone marrow failure. Full Story

 

Hadassah Researchers Witness Heart's Ability to Heal Itself

Researchers at the Hadassah University Medical Center witnessed the ability of the heart to heal itself, in the course of conducting a study on sheep where they implanted a stent into the left atrial appendage and found tissue growing inside the stent. Full Story
 

 

 
 
Researchers at the Hadassah University medical Center have discovered that over expression of an immune system Natural Killer (NK) cell called Neuroligin  4 can trigger cirrhosis of the liver by  preventing the body from combating scarring. Full Story
 
The ALS PhaseI/II safety trial of Brainstorm Cell Therapeutics' NurOwn stem cell therapy has been fast tracked to a Phase IIa dose-escalating trial by Israel's Ministry of Health and will be launched "immediately" at the Hadassah Medical Center, reports this leading developer of adult stem cell technologies for neurodegenerative diseases. Full Story
 
 
Cell Cure Neurosciences Receives Grant of $1.33 Million

Cell Cure Neurosciences Ltd., whose Chief Scientific Officer is Hadassah University Medical Center's Prof. Benjamin Reubinoff--Director of its Human Embryonic Stem Cell Research Center--received a 1.3 million-dollar grant from Israel's Office of the Chief Scientist (OCS) to help finance its development of a treatment for age-related macular degeneration (AMD). Full Story

 

Researchers at the Hadassah University Medical Center in Jerusalem have produced, for the first time, under Good Manufacturing Practices ( GMP) conditions, lines of human embryonic stem cells (hESCs) for transplantation that are free of animal components. Full Story
 
 
 
 
Israeli researchers, led by Dr. Asher Salmon, then Senior Oncologist at the Hadassah Medical Center, developed a blood test that reveals it is possible to predict the presence of harmful BRCA1 and BRCA2 mutations in otherwise healthy women using a novel technology called gene expression profiling. Full Story
 
To develop a unique stent locator based on the work of three Hadassah Medical Center heart specialists, Hadasit, Hadassah's Technology Transfer Company, has created an incubator company entitled AOL Medical. Full Story
 
Identifying the defective gene that has caused neuropathy in children of North African descent, physician/researchers at the Hadassah Medical Center have employed an experimental drug to prevent permanent paralysis of both muscle and vocal cords in four children. Full Story 

 

Hadassah Researchers Investigate Link Between "Love Hormone" and Development of Autism
Researchers at the Hadassah Medical Center are investigating the connection between lower levels of the hormone, oxytocin, during pregnancy and the development of autism. Full Story
 
 With a world-first placental stem-cell (PLX) treatment, developed by Pluristem, doctors at the Hadassah University Medical Center have saved the life of a third patient suffering from bone marrow disease. Full Story

 

 
Hadassah Pioneers New Treatment for Liver Cancer
The Hadassah University Medical Center, for the first time in Israel, has pioneered a new treatment for liver cancer, using a direct flow of high-voltage electric current to destroy a malignant tumor.Full Story
 
Enlivex ľ a Hadasit start-up company (under HBL) which develops a preventive immune-modulatory treatment invented by Prof. Dror Mevorach and his laboratory at Hadassah Medical Center - has successfully completed the first Phase I/IIa clinical trial for testing the safety and preliminary assessment of the effectiveness of ApoCell in the prevention and treatment of graft-versus-host disease (GVHD), a devastating and potentially life-threatening complication that occurs in 50-70% of patients receiving bone-marrow transplantation. Full Story
 
 
A clinical trial with TL-118--a new treatment for metastatic pancreatic cancer--that has been ongoing at the Hadassah University Medical Center and three other oncology centers in Israel, has been expanded to the United States. Full Story
 
A multidisciplinary team at the Hadassah Medical Center is testing the use of Deep Brain Stimulation (DBS) to alleviate depression in severely affected patients. Full Story

Share/Save/Bookmark